IE42137L - Compositions containing piperidyl xanthenes thioxanthenes¹and dibenzozepins - Google Patents

Compositions containing piperidyl xanthenes thioxanthenes¹and dibenzozepins

Info

Publication number
IE42137L
IE42137L IE752398A IE239875A IE42137L IE 42137 L IE42137 L IE 42137L IE 752398 A IE752398 A IE 752398A IE 239875 A IE239875 A IE 239875A IE 42137 L IE42137 L IE 42137L
Authority
IE
Ireland
Prior art keywords
dibenzozepins
xanthenes
compositions containing
piperidylidene
piperidyl
Prior art date
Application number
IE752398A
Other versions
IE42137B1 (en
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of IE42137L publication Critical patent/IE42137L/en
Publication of IE42137B1 publication Critical patent/IE42137B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Pharmaceutical compositions and a method of producing antipsychotic activity without extrapyramidial symptoms by administering internally a nontoxic effective quantity of a tricyclic piperidylidene derivative to an animal host. The active ingredients are prepared from an appropriately substituted xanthone, thioxanthone or dibenxoxepinons by reaction with an N-substituted piperidyl magnesium halide. Certain of the piperidylidene derivatives are novel compounds per se. [CA1055945A]
IE2398/75A 1974-11-06 1975-11-04 Compositions containing piperidyl xanthenes,thioxanthenes and dibenzozepins IE42137B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52121674A 1974-11-06 1974-11-06

Publications (2)

Publication Number Publication Date
IE42137L true IE42137L (en) 1976-05-06
IE42137B1 IE42137B1 (en) 1980-06-04

Family

ID=24075868

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2398/75A IE42137B1 (en) 1974-11-06 1975-11-04 Compositions containing piperidyl xanthenes,thioxanthenes and dibenzozepins

Country Status (17)

Country Link
JP (1) JPS5826754B2 (en)
AU (1) AU498298B2 (en)
BE (1) BE835224A (en)
CA (1) CA1055945A (en)
CH (1) CH624403A5 (en)
DE (1) DE2549841A1 (en)
DK (1) DK139429B (en)
ES (1) ES442357A1 (en)
FR (1) FR2290202A1 (en)
HU (1) HU174639B (en)
IE (1) IE42137B1 (en)
IL (1) IL48400A (en)
LU (1) LU73714A1 (en)
NL (1) NL7512974A (en)
NZ (1) NZ179139A (en)
PH (1) PH12158A (en)
ZA (1) ZA756550B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2357251A1 (en) * 1976-07-09 1978-02-03 Merck & Co Inc Carboxy-thioxanthenylidene-piperidine - useful as appetite stimulants and antiallergics
US4073912A (en) * 1976-10-12 1978-02-14 Smithkline Corporation Piperidylidene derivatives of benzo-fused xanthenes, thioxanthenes and dibenzoxepins and antipsychotic use thereof
US4089961A (en) * 1976-11-08 1978-05-16 Smithkline Corporation Antipsychotically useful quinolizidylidene derivatives of xanthenes, thioxanthenes and dibenzoxepins
NZ189108A (en) * 1977-12-29 1982-02-23 Kefalas As 2-methylthio-6-fluoro-9-(1-methyl-4-piperidylidene)-thioxanthene and pharmaceutical compositions intermediate 2-methylthio-6-fluoro-9-(1-methyl-4-piperidyl)-thioxanthen-9-ol
US4777177A (en) * 1984-10-19 1988-10-11 Ciba-Geigy Corporation Pesticidal thioxanthen-9-ylidenepiperidines
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
CA2004211A1 (en) * 1988-11-30 1990-05-31 Masataka Syoji Piperidine derivatives and hyportensives containing the same
EP1306376A1 (en) * 2001-10-25 2003-05-02 Biofrontera Pharmaceuticals AG Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
US7060711B2 (en) 2001-10-25 2006-06-13 Biofrontera Bioscience Gmbh Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
EP1644373A1 (en) * 2003-06-27 2006-04-12 Janssen Pharmaceutica N.V. Tricyclic delta opioid modulators
WO2007030089A1 (en) 2004-08-05 2007-03-15 Janssen Pharmaceutica N.V. Tricyclic delta- opioid modulators
CN101119992A (en) 2004-12-22 2008-02-06 詹森药业有限公司 Tricyclic delta-opioid modulators
US7439239B2 (en) 2004-12-22 2008-10-21 Janssen Pharmaceutica N.V. Tricyclic δ- opioid modulators
EP1836196A1 (en) * 2004-12-22 2007-09-26 Janssen Pharmaceutica N.V. Tricyclic delta-opioid modulators
JP2008526878A (en) 2005-01-06 2008-07-24 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Tricyclic δ-opioid regulator
CA2612491A1 (en) 2005-06-16 2006-12-28 Janssen Pharmaceutica N.V. Tricyclic opioid modulators
JP5044562B2 (en) 2006-09-29 2012-10-10 日本臓器製薬株式会社 Oxepin derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL260070A (en) * 1960-02-25
NL122808C (en) * 1961-09-29
DE1670118A1 (en) * 1966-07-22 1970-11-05 Boehringer Mannheim Gmbh Process for the preparation of new derivatives of 6,11-dihydro-dibenz [b, e] oxepins and their salts
US3470188A (en) * 1967-01-05 1969-09-30 Smithkline Corp 9-cycloalkyl-lower alkyl-piperidylidene derivatives of xanthenes and thioxanthenes
JPS5018478A (en) * 1973-05-17 1975-02-26

Also Published As

Publication number Publication date
NZ179139A (en) 1978-04-28
HU174639B (en) 1980-02-28
BE835224A (en) 1976-05-04
LU73714A1 (en) 1976-06-11
DK495775A (en) 1976-05-07
IL48400A (en) 1979-01-31
PH12158A (en) 1978-11-10
DE2549841C2 (en) 1988-07-07
NL7512974A (en) 1976-05-10
DK139429C (en) 1979-08-06
JPS5170768A (en) 1976-06-18
ES442357A1 (en) 1977-04-01
FR2290202B1 (en) 1980-05-23
CH624403A5 (en) 1981-07-31
DE2549841A1 (en) 1976-05-13
JPS5826754B2 (en) 1983-06-04
ZA756550B (en) 1976-09-29
IE42137B1 (en) 1980-06-04
AU498298B2 (en) 1979-03-01
FR2290202A1 (en) 1976-06-04
AU8624775A (en) 1977-05-05
IL48400A0 (en) 1976-01-30
DK139429B (en) 1979-02-19
CA1055945A (en) 1979-06-05

Similar Documents

Publication Publication Date Title
IE42137L (en) Compositions containing piperidyl xanthenes thioxanthenes¹and dibenzozepins
IE45256L (en) Quinazolone derivatives
NZ218786A (en) 1,4 disubstituted piperidine derivatives and pharmaceutical compositions
ATE13056T1 (en) INDANDERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND COMPOSITIONS CONTAINING THEM.
GB1507957A (en) Nitrofuryl-pyrazole derivatives methods for producing them and medicaments comprising them
ES8205353A1 (en) Sustained release tablets
HUT46224A (en) Process for producing pharmaceutical compositions containing prostaglandin e1-derivatives
HU173950B (en) Process for producing alpha,alpha-disubstituted acetic acid derivatives and pharmaceutical compositions containing them as active agents
ES8705763A1 (en) Pharmaceutical compositions containing gels.
DE3683822D1 (en) CHARTER REIN DERIVATIVES AND SALTS, THESE ANTITUARY COMPOSITIONS AND METHOD FOR THEIR PRODUCTION.
ES427079A1 (en) Phenothiazine derivatives, compositions thereof and methods of preparation thereof
ES434431A1 (en) 1'-substituted xanthene-9-spiro-4'-piperidine derivatives
JPS5646810A (en) Blood platelet coagulation inhibitor
IE800179L (en) Pharmaceutical compositions containing paracetamol.
ES466239A1 (en) Azacycloalkanes azacycloalkenes and derivatives thereof
GB1421589A (en) Salicylanilide derivatives
GB1276812A (en) Novel aminopiperidines, processes for their preparation, and compositions incorporating them
ES432439A1 (en) Xanthene and thioxanthene derivatives, compositions thereof and a method of preparation thereof
GB1498919A (en) Furanose-o-pyridylcarboxylic acid esters
HU174882B (en) Process for producing 1,12-methanooxymethano-indolo-square bracket-2,3-a-square bracket closed-quinolysine derivatives and pharmaceutical compositions containing them as active agents
IE43708L (en) D-homosteroid carboxylic acids
AU2997689A (en) Process for the preparation of thiophene derivatives and also new dihydrothiophene 1-oxides
GB1133080A (en) Improvements in or relating to derivatives of nitrofuran
IE38940B1 (en) Pharmaceutical compositions containing p-chlorohippuric acid or salts thereof
IE41106L (en) Pharmaceutical compositions containing benzylamines